Intellia Therapeutics
NTLA
NTLA
70 hedge funds and large institutions have $241M invested in Intellia Therapeutics in 2016 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 24 increasing their positions, 15 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
8% more funds holding
Funds holding: 65 → 70 (+5)
1% less capital invested
Capital invested by funds: $242M → $241M (-$1.43M)
Holders
70
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$6.92M | |
| 2 | +$5.65M | |
| 3 | +$1.38M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$886K |
| 5 |
AG
Artal Group
Luxembourg
|
+$590K |
Top Sellers
| 1 | -$8.07M | |
| 2 | -$6.55M | |
| 3 | -$3.42M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$2.32M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$1.41M |